chrisvoncsefalvay/vaers-outcomes huggingface dataset:
experiencing redness, swelling and tingling in the right side of the face; experiencing redness, swelling and tingling in the right side of the face; tingling in the right side of the face; This spontaneous case was reported by a health care professional and describes the occurrence of SWELLING (experiencing redness, swelling and tingling in the right side of the face), ERYTHEMA (experiencing redness, swelling and tingling in the right side of the face) and PARAESTHESIA (tingling in the right side of the face) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING (experiencing redness, swelling and tingling in the right side of the face), ERYTHEMA (experiencing redness, swelling and tingling in the right side of the face) and PARAESTHESIA (tingling in the right side of the face). At the time of the report, SWELLING (experiencing redness, swelling and tingling in the right side of the face), ERYTHEMA (experiencing redness, swelling and tingling in the right side of the face) and PARAESTHESIA (tingling in the right side of the face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
not received second dose due to COVID pandemic; This case was reported by a pharmacist via call center representative and described the occurrence of social problem in a 63-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose 2 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not received 2nd dose of Shingrix due to COVID pandemic, which led to Social problem. The reporter consented to follow up.
pt recv vax 14MAY97 & that same day pt was adm to hosp it was reported on 15MAY97 that the pt was symptomatically improved;
The patient felt dizzy and tired after the moderna booster. Afterwards, she fainted and passed away
By afternoon, pt had vomiting/diarrhea. Thought she had fever. Red and itching at site. Better on 11/25/99, then sx's started again on 11/26/99. Saw PMD who dx'd bacterial infection. Given antibiotic. Improved after that.
This case was reported by a consumer via call center representative and described the occurrence of pre-existing condition improved in a adult patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included migraine. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pre-existing condition improved and unexpected therapeutic effect. On an unknown date, the outcome of the pre-existing condition improved and unexpected therapeutic effect were unknown. It was unknown if the reporter considered the pre-existing condition improved and unexpected therapeutic effect to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The patient shared experience with the SHINGRIX drug. The patient had been getting around 30 migraines a month. The patient use to get migraines almost every day. After the patient's first injection, it was 8 days before the patient got a severe migraine. Something in the SHINGRIX positively affected the patient. The patient stated that the SHINGRIX was a really game changer. After the first shot, patient's migraines dropped to 3 a week. The patient reported the same to the company (GSK) however the email received by the patient was written by someone that did not read the patient's review. For patient to receive a single shot and drop 4 days of migraines was super. The patient advised that, GSK should pursue this affect and stated it was wondrous. The patient would get the second shot of SHINGRIX in about two months and the patient was hoping to get more of the same relief. The patient stated, this was not a complaint regarding the drug, but the response patient received.
administered the Shingrix second dose with less than the recommended time; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 69-year-old female patient who received Herpes zoster (Shingrix) (batch number 394KF, expiry date 14th October 2022) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The patient received 2nd dose of Shingrix, less than the recommended time interval, which led to shortening of vaccination schedule. The health care provider asked for scheduled time for Shingrix to decide how to proceed with 2nd dose. The reporter consented to follow up. This case is been linked with US2021094190, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021094190:same reporter
This is a spontaneous report from a contactable nurse received via a Pfizer sales representative. An 81-year-old female patient received PREVNAR 13, (batch/lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at a single dose for immunization given at the pharmacy. The patient's medical history and concomitant medications were not reported. On an unspecified date after immunization, the patient contacted her physician with concern over side effect experienced such as pain, swelling, itching, rash 6 cm diameter that started as knot, was diabetic, had hypertension (HTN) and high cholesterol. The outcome of the events was unknown. The events occurred after use of product. No follow-up attempts are possible, information about batch number cannot be obtained. Sender's Comments: Being diabetic, having hypertension and high cholesterol are not related to the use of PREVNAR 13 in the advanced old patient but represent the patient's underlying medical conditions. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Narrative:  Patient received Pneumovax 23 vaccine on 12/13/21, then saw his provider. Patient left his appointment and was driving home when the patient noted that he was having difficulty breathing and chest pressure/heaviness. Patient turned his car around and returned to the clinic where he was administered an epipen and oxygen. 911 was called and patient was transported to local hospital for evaluation.
Hives covering entire body. Received steroid shot and oral steroids on 12/10/18.
Td given right deltoid IM on 7/1/03. Returned to clinic on 7/3 with redness, swelling and warmth to right deltoid. No tenderness, no fever. Provider charted myositis vs allergy. Treated with cephalexin 500 mg tid for 10 days, Diphenhydramenol 25 mg po every 6 hours. Instructed to go the Peds Urgent Care for follow up 7/4 or sooner if needed.
Initial misuse report received from a healthcare professional on 20 June 2013. An adult patient had received TENIVAC vaccine in error instead of ADACEL. No adverse event was reported. Documents held by sender: None.
10 days p/vax-grand mal sz-10 mins in duration; no other sx; temp ? ear temp 99; pt recovered but mom described pt as not self for about 4-5 days;
Patient is a 58-year-old, female. Alert, oriented X4, clear speech, able to answer to questions. No known medical conditions. History of allergies to Hydrocodone. Patient requested to be vaccinated in anti-gravity chair. At 9:06 am, the patient received her second dose of Pfizer (lot number EW0185, expires on 08/2021) on right deltoid. At 9:25 am, patient notified EMT that she was experiencing lightheadedness, dizziness, nausea and ringing in ears. EMT gave patient emesis bag and began taking patient's vitals. Patient remained A&Ox4 and talking to EMT. At 9:27 am: BP of 122/70, HR 71, SPO2 99%. EMT reclined patient in chair and encouraged deep breathing. At 9:35 am: BP 124/74, SPO2 99%, HR 71. Patient states she had a light breakfast, so EMT offered patient a snack. Patient consumed 1 granola bar. Patient states she experienced ringing in ears for approximately 2 weeks following her first dose. Patient did not seek medical treatment. RN provided patient with education related to adverse reactions to vaccine. RN recommended patient talk to PCP about persistent ringing in ears. At 9:48 am: BP 122/80, SPO2 99%, HR 76. At 9:52 am, patient reports slight ringing in ears. Patient denies headache. Patient still experiencing "slight" dizziness. Patient requesting to leave site at 9:55 am. Lead RN provided patient with education concerning when to call 9-1-1, including worsening of symptoms and trouble breathing. Patient was instructed to follow up with PCP. At 9:56 am, patient walked to car with steady, balanced gait.
Red rash for one week on arms, trunk, head and legs.  Fever on 08/31/2005. A few blisters observed by parent.
patient developed a band shaped rash 3 inches below the injection site. The rash was swollen and feels hot to the touch
4/4/21 woke up more tired than usual. Progressed from there, prominent fatigue for the next couple days, slept on the couch on and off for a couple days which was unusual for him. Mild SOA and weakness 4/7/21. Died in his sleep into the morning of 4/8/21.
itchy rash; A mild rash has also now formed along my ribcage; fever; chills; headache; body aches; sore throat; nausea; This is a spontaneous report was received from a contactable Other-HCP (patient). A 21-year-old non pregnant female patient received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number EL3247) via an unspecified route of administration, administered in left arm on 16Feb2021 10:15 AM (at age of 21-year-old) as single dose for covid-19 immunisation. Not pregnant at the time of vaccination. The patient medical history not provided. Known allergies: blueberries. Concomitant medications included valacyclovir, JUNEL FE taken for birth control. The patient had received 1st dose of BNT162B2 Batch/lot number: EL3247 on 26Jan2021 at 10:15AM at left arm. On 16Feb2021, Fever that started at 3:00pm bouncing between 100.8 and 101.8, chills and headache started at 12:30pm, body aches, sore throat, nausea. On 17Feb2021, the patient had a mild itchy rash started on the middle of the front of my arms, in the elbow crease. Seemed to go away quickly with cortisone cream but had been popping up again on and off every day. Today the patient woke up to a very itchy rash in the same area that now extends all the way down the arm and up to the shoulder. A mild rash had also now formed along her ribcage. The patient did not take other vaccine in four weeks and prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has the patient has not been tested for COVID-19. The patient received treatment as cortisone cream for event itchy rash and rash, for rest all no treatment. The patient did not have covid prior vaccination and was tested post vaccination. Upon follow up#1, the first dose received date, medical history, event, and concomitant medications were updated. the patient was not recovered from the events.  Follow-up (17Feb2021): This is a follow-up spontaneous report from a contactable Other-HCP. This Other-HCP reported that the first dose received date, medical history, event, and concomitant medications were updated.  Follow-up (01Mar2021): This is a follow-up spontaneous mail trail received in response to the query sent regarding the confirmation of PRD. This report included that: awareness date was 17Feb2021  Follow-up (24Feb2021): This is a follow-up spontaneous mail trail received in response to the query sent regarding the confirmation of Onset date of AE. This report included that the onset date of AE was 16Feb2021, but the reporter did not have the ability to submit a report until 17Feb2021.  Follow-up (14May2021): Follow-up attempts completed. No further information expected.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. No pertinent medical history, drug reactions/allergies or concurrent conditions were reported. On 30-MAR-2016, the patient was vaccinated with improperly stored PROQUAD (which had a lot # reported to be L044057 and an expiration date of 02-MAY-2017; however dose, dosage number and route of administration were not reported). The temperature excursion involved was 13F and the time frame of the excursion was 4 hours. However, no adverse effects were reported. Additionally, it was stated that there were no previous temperature excursions. Also, no product quality complaint was involved. This is one of the two reports received from the same reporter. Additional information has been requested.
I had my fourth Pfizer shot on 4/6/2022. I suffer from seasonal allergies every year. About two weeks after my shot, my allergies worsened and I was concurrently exposed to Covid. My son, husband, daughter, daughter-in-law, cousin and grandson all tested positive between 4/16/2022 and 4/19/2022 (rapid Antigen home test). I tested negative but was having either mild covid symptoms or allergies (sore throat and "stuffed" sinuses. On 4/22/2022 I went for a PCR test which tested positive.  On 5/3/2022 I tested negative (home rapid Antigen test). I continued to have mild symptoms and fatigue so  called my doctor on 5/6/2022 as my left cheek and teeth hurt and my nose dripped yellow snot. She started me on a Zpack.  On 5/10/2022 I flew (for the first time since covid and wore a mask during the journey) During that period I was away, I had mild fatigue, chills at night, sore throat. I went to see the doctor on 5/17/2022. She confirmed the sinus infection still present and started me on a three day course of Prednisone and a new antibiotic (Cefuroxime). I am beginning to feel better.
Received dose 1 on 1/27/2021.  On 2/7/21, patient experienced RLE weakness, gait imbalance, and leaning to the right side. CT showed no acute intracranial hemorrhage however MRI of brain demonstrated acute infarction of the posterior limb of the left internal capsule. Patient was admitted to inpatient acute rehab due to issues with self-care, safety awareness and ambulation.
Information has been received from a health authority concerning a 7 month old male who on 31-MAY-2007 and 01-AUG-2007 was vaccinated PO with his first and second doses of Rotateq (batch# not reported, lot# not reported). On 09-AUG-2007, a week after administering the second dose, the patient was diagnosed with colitis and bloody diarrhea and was hospitalized. The patient has been diagnosed with undetermined colitis, presenting an inflammatory intestinal manifestation that affects both bowel and small intestine. Relevant diagnostic studies included: a negative stool test, abnormal barium enema test, abnormal intestinal biopsy and abnormal colonoscopy. The following lab tests were discarded: cow's milk protein intolerance and the negative coprocultives test. The patient was not recovered yet. Other business partner numbers include: E2008-00422, ES-AGEMED-122669332. Additional information has been requested.
First Shingrix Vaccine was given on Oct. 9, 2019. The only side effect was the severe, severe pain on left arm going down to fingers. Very painful that couldn't even sleep at night & was suffering so much thru entire arm. Second shingrix Vaccine was given on 12/06/2019. This time I asked to inject on the other arm (Right arm.) Same thing; soon after the injection, the pain started. Severe pain on that side from shoulder to hand & fingers & unable to sleep and same as first one it lasted 2 days. On December 10, 2019 I experienced redness & itching on my both palms & forearms up to elbow. half of my both palms at the same time going up on inner side of the arm. My palms were itching so badly, redness, pain was hurting so much gradually. Half of my palms on each side became very Sensitive & painful. I couldn't touch the skin at all, couldn't hold any object & was unable to drive. The pain & rashes and the scaring look of rashes on both arms and both thighs made me go to Emergency Room at Hospital. Was there for hours & they told me it could have been the side effects of the vaccination. While waiting, they gave me the following shot & medications: dexamethasone (DECADRON) 4mg/mL injection 10mg Intramuscular); diphenhydAMIN (BENADRYL) capsule 25mg; famotidine (PEPCID) tablet 20mg. They also did lab test. Was told to use cream & Benedryl at home & prescribing methylPREDNISolone (MEDROL DOSEPAK) 4mg tablet for a week at home. The appearance of these spot on my thighs was so bad, to me looked close to a shingle. If the skin was reacting like that, how the internal organs were affected? For days, I was dealing with it & while the arms & thighs were getting better, my both shins started to show rashes & again spreading to my calf and were so itchy & painful.
Aching joints, especially hands - 12 hours.  Fever, 100.0 - intermittently for 7 days. 2 inch diameter around vaccination site, sore, red, fevered, bruising, itching, and swollen - 2 hours after vaccination and continuing. Lightheaded, dizzy - severely for 30 minutes after vaccination and intermittently for 7 days. Nauseous - for 72 hours after vaccination.
The patient was brought to the ED by his wife shortly after 10am for his stroke-like symptoms; approximately 10 hours after his influenza vaccination. Left-sided facial droop, numbness, and tingling. He was discharged with a diagnosis of Bell's palsy, and was prescribed Valtrex, prednisone, and eye ointments. After 3 weeks, he fully recovered, though he had difficulty eating and drinking during that time and could not eat.
After patient would receive set of immunizations couple months apart would get very high fever.  I would call physician back and was told is normal to give Tylenol or Motrin for fever and pain.
Patient was in garden shoveling hole, lost balance, fell down brick steps and landed on patio and was able to catch herself on chair. She did not hit head, is feeling fine now. She reported having balance issues, but this felt different than the other incidents. No other side effects from vaccine.
Patient slept for the first 24 hours, ran a slight fever (all normal reactions). When she woke up, she began to cycle through episodes of shrieking, then like a light switch she would stop, and appear vacant and non-responsive. Her eyes glassed over. At one point (at about 5 pm) I was holding her and her body stiffened and shot upwards. I called my pediatrician and talked to Dr. who was on call. I assumed they had filed this report, but upon asking, they had not filed a VAERS.
Patient reported feeling warm with sensation of facial warmth. Patient had tachycardia and reported the sensation of throat closing. Epinephrine (Epi pen) administered and held in place for 3 seconds, Airway, Breathing, Circulation, and level of consciousness assessed and stable at 1450, Benadryl 50mg administered as a single dose. Second dose of Epinephrine administered. Patient transported via family member to ED.
Patient reported received Pfizer COVID-19 vaccine 2 dose series 3/4/2021 and 3/31/2021. PT tested positive for COVID-19 5/20/2021 via nasal swab.
I felt feverish and weak flu like symptoms, a home test was positive.  I contacted healthcare provider via telehalth was prescribed Paxlovid took aregiment for five days,  life returned
Dizzy/dizziness; Nausea; Fatigue; first day after administration of the vaccination the patient fainted; Diastolic in the 40s; Heart squeezing; Unresponsive for 30 seconds; A spontaneous report was received from a consumer concerning a female patient who experienced unresponsiveness for 30 seconds/altered state of consciousness, dizzy/dizziness, diastolic in the 40s/blood pressure diastolic decreased, heart squeezing/palpitations, dizziness, fainting/syncope, nausea and fatigue.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.     On 10 Feb 2021, approximately 10 days prior to the onset of the symptoms, the patient received second of two planned doses of mRNA-1273 (Batch number not provided) for prophylaxis of COVID-19 infection.    On 10 Feb 2021, the patient reports she received the second dose of the vaccine. On day one was unresponsive for 30 seconds and has been dizzy since. The next day she fainted after administration of the vaccine. The first 5 days after receiving the vaccination, patient felt like her heart was being squeezed. Diastolic dropped to 40s and heart rate has not been higher than 70. On following up, she reports having nausea and fatigue now along with dizzy feelings. Treatment information was not provided/unknown.    The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events is not applicable.  The outcome of the events, unresponsiveness for 30 seconds/altered state of consciousness, diastolic in the 40s/blood pressure diastolic decreased, heart squeezing/palpitations and fainting/syncope, were considered resolved.  The outcome of the events, dizzy/dizziness, nausea and fatigue, were considered unknown.   Follow-up received on 19 Feb 2021 included that the patient now has nausea, fatigue and dizziness.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pt recvd 3 doses of Engerix-B & neg titer result; will revax pt;
Patient reports feeling dizzy looks pale and notifies EMT staff and supervisor. VS are taken at 12:45pm BP 100/60, P52. 12:55 VS are taken BP 110/80, P68, R20/min. 1:20pm VS are taken again BP 100/70, P68/min and R16/min. Patient looks active and reports feeling better and walks away.
Patient was very nauseous, pale, feeling like throwing up, hot flashes, felt like he was sweating but was not actually perspiring. He also had an unconfirmed mini seizure. EMTs came in and check his tongue and concluded that he did not have a seizure because he did not bite his tongue. The EMTs did an EKG on the patient, checked his pulse and blood pressure. His blood pressure was low (85/50) and they took the patient to the hospital.